Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus, page-205

You could look at this 2 ways: 1) good to have choice of 15 compounds shows how great their library must be or 2) they’re going to now waste more time and money chasing 15 leads to try to find the 1 to take into further development.
this outfit might be better off not wasting everyone’s time going off on these expeditions that will go nowhere - there are treatments for C19 and you only need to look at the 1000s of ongoing clinical trials on clinical trials.gov to see how far behind these guys are anyway. Wasteful. Why not focus on their core HIV programme and build on phase 2. How effective is the leadership of this co? Impression I get reading about this co is scientists hobby working at snail pace in spare time plus a job for life CEO, looks too comfortable and cruisy.